Sign In | Join Free | My resportshoes.com
resportshoes.com
Products
Search by Category
Home > Chemical Reagents >

Glucagon Growth Hormone Releasing Peptide / GLP-1 7-37 Acetate For Diabetes Mellitus Treatment

Categories Growth Hormone Peptides
Brand Name: Biopro
Model Number: GHP-07
Certification: GMP,ISO9001,KOSHER
Place of Origin: China
MOQ: Negotiation
Price: Negotiation
Payment Terms: Western Union, MoneyGram, T/T
Supply Ability: Mass in stock
Delivery Time: Within 24 hours after payment
Packaging Details: 2mg/vial or as your request
Product name: GLP-1 (7-37) Acetate
CAS: 106612-94-6
MW: 3355.74
MF: C151H228N40O47
Appearance: White Powder
Purity: 99%
  • Haven't found right suppliers
  • Our buyer assistants can help you find the most suitable, 100% reliable suppliers from China.
  • And this service is free of charge.
  • we have buyer assistants who speak English, French, Spanish......and we are ready to help you anytime!
  • Submit Buying Request
    • Product Details
    • Company Profile

    Glucagon Growth Hormone Releasing Peptide / GLP-1 7-37 Acetate For Diabetes Mellitus Treatment

    Glucagon Growth Hormone Releasing Peptide / GLP-1 7-37 Acetate For Diabetes Mellitus Treatment

    Description

    Glucagon-like peptide-1 (GLP-1) is derived from the transcription product of the proglucagon gene. The major source of GLP-1 in the body is the intestinal L cell that secretes GLP-1 as a gut hormone. The biologically active forms of GLP-1 are:GLP-1-(7-37) and GLP-1-(7-36)NH2.

    GLP-1 secretion by L cells is dependent on the presence of nutrients in the lumen of the small intestine. The secretagogues (agents that cause or stimulate secretion) of this hormone include major nutrients like carbohydrate, protein and lipid. Once in the circulation, GLP-1 has a half life of less than 2 minutes, due to rapid degradation by the enzyme dipeptidyl peptidase-4.

    GLP-1 (7-37) is a truncated, bioactive form of GLP-1 that is the product of proglucagon processing in intestinal endocrine L cells. It is a potent insulinotropic hormone.

    Specification

    GLP-1 (7-37) Acetate
    Sequence: His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly
    Alias : 7-37-Glucagon-likepeptide I (human);Glucagon-relatedpeptide 1 (Rana catesbeiana),3-L-glutamicacid-10-L-valine-16-glycine-17-L-glutamine-23-L-isoleucine-24-L-alanine-27-L-valine-31-glycine-32-de-L-lysine-
    Cas No.: 106612-94-6
    Molecular Formula: C151H228N40O47
    M.S.:

    Glucagon HGH Human Growth Hormone Peptide GLP-1 7-37 Acetate For Diabetes Mellitus Treatment

    Molecular Weight: 3355.74
    Purity (HPLC): 99.0%
    Appearance: White powder
    Single Impurity (HPLC): 1.0%
    Amino Acid Composition: 10% of theoretical
    Peptide Content (N%): 80% (by %N)
    Water Content (Karl Fischer): 6.0%
    Acetate Content (HPIC): 15.0%
    Grade : Pharmaceutical Grade
    Storage: Closed, below 2 ~ 8℃ preservation
    Usage : GLP-1 can obviously improve the blood glucose in type 2 diabetes animal models or patients through a variety of mechanisms, which promote the regeneration and repair of islet beta cells, increase the number of beta cells is particularly significant role, provides a very good prospect for the treatment of type 2 diabetes mellitus.

    Application

    Effect of GLP-1 GLP-1 can protect beta cells can act on the pancreatic beta cells, promote the synthesis of insulin, insulin gene transcription and secretion and can stimulate the proliferation and differentiation of islet beta cells, inhibit the apoptosis of pancreatic beta cells, increase the number of beta cell of islet [2-5]. In addition, GLP-1 also can be applied to the pancreatic alpha cells, strongly inhibit the release of glucagon, and act on the islet delta cells, promote the secretion of somatostatin, somatostatin cells and can be used as a paracrine hormone involved in the inhibition of glucagon.

    GLP-1 with glucose concentration dependent hypoglycemic effect, i.e. only rise in glucose levels under the condition of GLP-1, only play a hypoglycemic effect, but in normal blood sugar levels, caused no further decrease. The glucose concentration dependence of the GLP-1 is its hypoglycemic properties of clinical application safety of foundation and security, thereby avoiding people may cause severe hypoglycemia in patients with existing drug treatment for diabetes and scheme of worry.

    Physiological functions of GLP-1 include
    GLP-1 possesses several physiological properties that make it (and its analogs) a subject of intensive investigation as a potential treatment of diabetes mellitus, The known physiological functions of GLP-1 include:
    increases insulin secretion from the pancreas in a glucose-dependent manner.
    decreases glucagon secretion from the pancreas.
    increases beta cells mass and insulin gene expression.
    inhibits acid secretion and gastric emptying in the stomach.
    decreases food intake by increasing satiety.

    Peptides
    HGH 176-1912mg/vial 10vials/kit 1g/bag
    GHRP-25mg/vial 10vials/kit 1g/bag
    GHRP-210mg/vial 10vials/kit 1g/bag
    GHRP-65mg/vial 10vials/kit 1g/bag
    GHRP-610mg/vial 10vials/kit 1g/bag
    MGF2mg/vial 10vials/kit 1g/bag
    PEG MGF2mg/vial 10vials/kit 1g/bag
    CJC-1295 with DAC2mg/vial 10vials/kit 1g/bag
    CJC-1295 without DAC2mg/vial 10vials/kit 1g/bag
    PT-14110mg/vial 10vials/kit 1g/bag
    Melanotan-110mg/vial 10vials/kit 1g/bag
    Melanotan-210mg/vial 10vials/kit 1g/bag
    Ipamorelin2mg/vial 10vials/kit 1g/bag
    Hexarelin2mg/vial 10vials/kit 1g/bag
    Sermorelin2mg/vial 10vials/kit 1g/bag
    Oxytocin2mg/vial 10vials/kit 1g/bag
    TB5002mg/vial 10vials/kit 1g/bag
    Pentadecapeptide BPC 1572mg/vial 10vials/kit 1g/bag
    Triptorelin2mg/vial 10vials/kit 1g/bag
    Gonadorelin2mg/vial 10vials/kit 1g/bag
    Gonadorelin10mg/vial 10vials/kit 1g/bag
    Tesamorelin2mg/vial 10vials/kit 1g/bag
    DSIP2mg/vial 10vials/kit 1g/bag
    Selank5mg/vial 10vials/kit 1g/bag



    If you are interested in GLP-1 (7-37) Acetate or Other Polypeptide, please feel free to contact me, I will reply you at soonest time.

    Contact PersonTina
    Emailtina@bioproco.com





















































    Quality Glucagon Growth Hormone Releasing Peptide / GLP-1 7-37 Acetate For Diabetes Mellitus Treatment for sale
    Send your message to this supplier
     
    From:
    Enter your email please.
    To: Biopro Chemicals Co., Ltd.
    Subject:
    Message:
    Characters Remaining: (0/3000)
     
    Inquiry Cart 0